Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons

Romaine Charles Nichols1, Michael Rutenberg2

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL 32206, United States. rnichols@floridaproton.org.

Summary

Proton therapy for pancreatic cancer shows promise in improving local-regional control without increasing surgical complications. This approach offers a potential solution for enhancing treatment outcomes in resectable pancreatic cancer patients.

Related Concept Videos